SurgePays, Inc. (SURG) P/E Ratio History
Historical price-to-earnings valuation from 2023 to 2024
Loading P/E history...
SURG Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, SurgePays, Inc. (SURG) trades at a price-to-earnings ratio of -0.2x, with a stock price of $0.56 and trailing twelve-month earnings per share of $-2.12.
The current P/E is 102% below its 5-year average of 10.4x. Over the past five years, SURG's P/E has ranged from a low of 3.3x to a high of 30.2x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Technology sector median P/E of 27.7x, SURG trades at a 101% discount to its sector peers. The sector includes 359 companies with P/E ratios ranging from 0.0x to 184.2x.
Relative to the broader market, SURG trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our SURG DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
SURG P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $1B | 41.7 | - | +38% | |
| $624M | 13.6 | - | +24% | |
| $210B | 20.0 | 0.67Best | +1% | |
| $114B | 29.8 | 2.04 | +31% | |
| $4B | 43.4 | - | -64% | |
| $1B | 10.6 | 1.18 | +27% | |
| $451M | 8.1Lowest | - | +319%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
SURG Historical P/E Data (2023–2024)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $3.19 | $0.11 | 30.2x | +190% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $3.85 | $1.17 | 3.3x | -68% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $6.45 | $1.41 | 4.6x | -56% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $4.68 | $1.42 | 3.3x | -68% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $7.31 | $0.81 | 9.0x | -13% |
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $4.49 | $0.37 | 12.0x | +16% |
Average P/E for displayed period: 10.4x
See SURG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SURG Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SURG vs NVDA
Side-by-side business, growth, and profitability comparison vs NVIDIA Corporation.
Start ComparisonSURG — Frequently Asked Questions
Quick answers to the most common questions about buying SURG stock.
Is SURG stock overvalued or undervalued?
SURG trades at -0.2x P/E, below its 5-year average of 10.4x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does SURG's valuation compare to peers?
SurgePays, Inc. P/E of -0.2x compares to sector median of 27.7x. The discount suggests lower growth expectations or higher risk.
What is SURG's PEG ratio?
SURG PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2023-2024.